Mature T cells recognize and respond to the antigen/MHC complex through their antigen-specific receptors (TCR). The most immediate consequence of TCR activation is the initiation of signaling pathways including induction of specific protein tyrosine kinases (PTKs), breakdown of phosphatidylinositol 4,5-biophosphate (PIP2), activation of protein kinase C (PKC) and elevation of intracellular calcium ion concentration. These early events are transmitted to the nucleus and result in
clonal expansion of T cells,
upregulation of activation markers on the cell surface,
differentiation into effector cells,
induction of cytotoxicity or cytokine secretion, and
induction of apoptosis.
One of the most common ways to assess T cell activation is to measure T cell proliferation upon in vitro stimulation of T cells via antigen or agonistic antibodies to TCR.
This protocol is written as a starting point for examining in vitro proliferation of mouse splenic T-cells and human peripheral T cells stimulated via CD3. All steps where optimization by the user can be achieved for meaningful results have been highlighted. Briefly, these include titration of the cell concentration used, titration of the activating reagents and the optimal culture period for the best activation response.
1X sterile PBS
Anti-mouse CD3e, 145-2C11:
Supplemented RPMI-1640 <click here> for recipe
Sterile single-cell suspension of mouse spleen or lymph nodes
96-well flat-bottom microtiter plates with lids (Costar Cat. No. 3596)
MTT Buffer <click here> for recipe
MTT Lysing Solution <click here> for recipe
Concanavalin A, optional (ConA, Sigma Cat. No. C5275)
Pipettes and pipettors, Multichannel pipettor
Centrifuge
37°C, CO2 incubator
96-well micro test spectrophotometer
20 minutes antibody preparation for coating wells
20 minutes preparation of spleen single cell suspension
20 minutes to set up the assay
2-4 days incubation
Prepare a 5-10 μg/ml solution of anti-CD3e (145-2C11) in sterile PBS. Calculate the number of wells required for each experimental condition and consider triplicate samples for each condition. For example, to coat one-half plate (48 wells) 2.6 ml of antibody solution is required.
Note: We have performed titration studies and found these concentrations of 145-2C11 to induce a maximal response. However, a pilot experiment to determine efficacy of other concentrations of this antibody to induce cellular activation can be performed. For co-stimulation studies using antibodies to other antigens, a suboptimal activation with anti-CD3 may be required. To achieve suboptimal activation via anti-CD3, a 0.5-0.1 μg/ml 145-2C11 antibody solution can be used.
Dispense 50 μl of the antibody solution in each well of the 96-well assay plate. For the control unstimulated wells, add 50 μl of sterile PBS.
Tightly cover the plate with Parafilm to avoid sample evaporation and incubate at 37°C for 2 hours or alternatively prepare the plate one day in advance and keep at 4°C overnight.
Just before adding cells, remove the 50 μl antibody solution with a multichannel pipettor.
Rinse each well with 200 μl of sterile PBS and discard PBS.
Repeat step 5 to remove all unbound antibody from each well.
Harvest spleen and prepare a single cell suspension under sterile condition. Follow the red cell lysis protocol to remove red cells. <click here> for RBC lysis protocol.
Count cells and resuspend in complete RPMI-1640 at 106/ml.
Note: This concentration of spleen cells gives a good response. If experimental conditions require, a titration of cell concentrations (2-3 x 106/ml to 105/ml) should be performed for optimization.
After washing the wells with PBS (step 6 above), add 200 μl of the cell suspension to each well and place in a humidified 37°C, 5% CO2 incubator.
Note: For an additional stimulation control, incubate cells in 3 wells with Concanavalin A at 1-4 μg ConA per ml of culture medium.
Incubate for 2-4 days.
Note: Proliferation of cells between days 2 and 4 gives a good signal; however, this incubation time can also be optimized for specific experimental conditions.
Add 20 μl of the MTT buffer to each well and put back in the incubator for 4 hours.
Add 50 μl of the MTT Lysis Solution to each well, vortex gently and incubate overnight
Read the plate at 570 nm the next day.
Calculate the mean and standard errors and graph the data.
Human PBMCs can be activated in vitro by soluble anti-human CD3 antibodies. We have performed titration studies with these antibodies and established the following protocol for stimulation of PBMC.
1X sterile PBS
Anti-human CD3:
Supplemented RPMI-1640 <click here> for recipe
Sterile PBMC
96-well flat-bottom microtiter plates with lids (Costar Cat. No. 3596)
MTT Buffer <click here> for recipe
MTT Lysing Solution <click here> for recipe
Pipettes and pipettors, Multichannel pipettor
Centrifuge
37°C, CO2 incubator
96-well micro test spectrophotometer
30 minutes preparation of PBMC
20 minutes to set up the assay
2-4 days incubation
Prepare PBMC and resuspend the cells at 1-2 x 106/ml of supplemented RPMI.
Note: This concentration of PBMC gives a good response. If experimental conditions require, a titration of cell concentrations (2-3 x 106/ml to 105/ml) should be performed for optimization.
Add 100 μl of the cell suspension to each well. For each condition, use triplicate wells.
Add soluble antibody in 100 μl to each well. Titrate antibodies for optimal performance in the assay conditions used. If isolated T cells are to be used in proliferation assays, we recommend using these antibodies at 10 μg/ml immobilized on plastic (i.e. bound to wells of 96-well assay plates).
Place in a humidified 37°C, 5% CO2 incubator.
Incubate for 2-4 days.
Note: Proliferation of cells between day 2 and 4 gives a good signal; however, this incubation time can also be optimized for specific experimental conditions.
Add 20 μl of the MTT buffer to each well and put back in the incubator for 4 hours.
Add 50 μl of the MTT Lysis Solution to each well, vortex gently and incubate overnight.
Read the plate at 570 nm the next day.
Calculate the mean and standard errors and graph the data.
900 ml RPMI-1640 (Hyclone Cat. No. SH30027.02)
100 ml FBS (Hyclone Cat. No. SH30151.03) Heat inactivated (10% final)
1 ml 2-mercaptoethanol (GibcoBRL Cat. No. 21985-023)
10 ml L-Glutamine (Hyclone Cat. No. SH30034.01)
Antibiotic cocktail (optional)
MTT (Sigma Cat. No. M5655) make a 5 mg/ml stock solution in 1X PBS - Keep protected from light.
20% SDS 50% DMF
文|《中國科學報》記者李思輝實習生何睿她是一位知名三甲醫院的科室主任:不僅負責科室的管理工作,而且每周4個半天坐診,每年主刀800多臺手術;她是院士師門的“大師姐”:繁忙的臨床工作之余,做研究、帶學生......
Fanzor(Fz)是一種廣泛存在于真核生物結構域的ωRNA引導內切酶,具有獨特的基因編輯潛力。2024年8月28日,麻省理工學院/博德研究所張鋒團隊在Cell在線發表題為“Structuralins......
葉綠體蛋白在ATP酶馬達的驅動下,通過葉綠體外膜(TOC)轉座子和葉綠體內膜(TIC)超復合體的轉座子導入。Ycf2-FtsHi復合體已被確定為葉綠體進口馬達。然而,其在前蛋白轉運過程中與TIC復合物......
文| 《中國科學報》記者李思輝實習生畢若雪“2021年暑假的一個凌晨,我突然靈機一動,思考了很久的一個模型突然清晰起來。我立即從床上蹦起來,花了5分鐘,在紙上把它清楚地畫了出來!”說起最近發......
“一稿多投”一直被認為是不端的行為,但這個“規矩”是在紙質時代信息溝通不暢的情況下制定的,近年來廣大作者呼吁取消這一觀念的聲音已振聾發聵!讓人欣喜的是,截止目前,已經有兩大國際知名出版社響應了這一呼吁......
2024年4月23日,北京理工大學生命學院肖振宇副教授、中國科學院動物研究所王紅梅、于樂謙、郭靖濤研究員、中國農業大學魏育蕾教授、鄭州大學第一附屬醫院何南南助理研究員在國際學術期刊Cell發表文章《3......
2019年10月3日,加州大學圣地亞哥分校BrendaL.Bloodgood團隊(G.StefanoBrigidi為第一作者)在Cell在線發表題為“GenomicDecodingofNeuronal......
美國賓夕法尼亞大學佩雷爾曼醫學院科研人員發現,螞蟻的血腦屏障在控制其行為方面起著積極的作用。血腦屏障可以調節螞蟻大腦中的激素水平,從而影響他們在蟻群中的行為。相關研究成果發表在《Cell》雜志上。研究......
RNA引導系統利用引導RNA和靶核酸序列之間的互補性來識別遺傳元件,在原核生物和真核生物的生物過程中都起著核心作用。例如,原核CRISPR-Cas系統為細菌和古細菌提供了對外來遺傳因子的適應性免疫。C......
大約700萬年前,人類從我們最接近的動物親戚黑猩猩那里分離出來,在進化樹上形成了我們自己的分支。在此后的時間里---從進化的角度看是短暫的---我們的祖先進化出了使我們成為人類的性狀,包括比黑猩猩大得......